SurgiCount+ Safety-Sponge System Launches Reports Stryker

SurgiCount+ Safety-Sponge System, is Stryker’s next generation surgical sponge counting technology.

SurgiCount+ is Stryker’s most intelligent surgical sponge counting technology and allows healthcare providers to count and scan sponges and connect to hospital electronic medical records (EMR). Built on Stryker’s existing technology, it is designed to assist with sponge management, a leading safety concern in the operating room (OR) due to inadequate tools, manual processes and inconsistent practices.

One out of every 11 cases has a missing sponge,1 resulting in nurses spending almost 10 minutes searching.2 Current data show sponges are the number one retained surgical item3 – occurring 11 times a day in the U.S. alone.1 This negatively impacts patients and causes millions of dollars in costs for hospitals each year.

“Stryker is collaborating with surgical teams across the country to create safer ORs and equip healthcare providers with the tools needed to avoid retained surgical sponges,” said Mike Carlin, Vice President and General Manager of Stryker’s Surgical Technologies business. “We want healthcare providers to know they can count on us to make zero retained surgical sponges* the expectation and reality and provide certainty when they need it most.”

SurgiCount+ advances Stryker’s mission of making healthcare better by simplifying workflow and streamlining processes, resulting in less time spent searching for missing sponges. To date, medical staff have trusted SurgiCount in over 16 million procedures with zero retained sponges*. Features of SurgiCount+ include:

  • UHF-RFID tagged sponges enabling unique identification, eliminating false-correct, duplicate or unknown counts
  • A wireless reader for scanning, counting and finding sponges in the operating room
  • Intuitive, user-friendly tablet interface
  • A workstation stand equipped with sponge hanging bags and sterile reader covers situated on wheels for easy maneuverability and minimal floor space
  • A digital platform enabling EMR connectivity and documented proof

1 Makary, M et al. “Medical error—the third leading cause of death in the US.” The BMJ (May 2016). Web. Sept. 2016.

2 Double-blinded survey of 154 Operating Room Nurses from 154 different facilities across the United States. Data on file internally. Conducted August 2020.

3 The Joint Commission. “Preventing unintended retained foreign objects.” Sentinel Event Alert. Issue 51. Oct. 2013.

* When used and implemented correctly

SourceStryker

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”